PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder

About This Study

This is a Phase 2 double-blind, long-term observational follow-up study of participants from Study PSIL201. Participants providing informed consent will be enrolled into this study and will complete web surveys and telephone interviews conducted by one central site at the following time intervals: months 2, 3, 4, 5 and 6 (± 7 days for each assessment) and months 8, 10, 12, 14, 16, 18, 20, 22 and 24 (± 14 days for each assessment).

Conditions Studied

Interventions

• •No intervention will be administered as part of this study.

Eligibility

Inclusion Criteria:

* Enrollment and intervention with the investigational drug in Study PSIL201

Exclusion Criteria:

* Inability or unwillingness to complete study procedures, including regular completion of web surveys and telephone interviews with study personnel

Study Locations (1)